For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

Many studies have used single-cell RNA sequencing (scRNA-seq) to infer gene regulatory networks (GRNs), which are crucial for ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

However, the mechanisms through which these anti-ACE2 antibodies are induced during SARS-CoV-2 infection are unclear ... Structural Prediction and Docking of the Antigen-Binding Fragment of mAb 127 ...

The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.

Latent Labs, the company building AI foundation models to make biology programmable, today emerged from stealth with $50M in total funding to accelerate their progress and partnerships.

Backed by influencial names in the life sciences industry, Latent Labs offers an AI platform to accelerate and improve drug ...

Biomedical engineers at Duke University have demonstrated a new synthetic approach that turbocharges bacteria into producing ...

As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...